ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,891.10
1.59%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Rocket Pharmaceuticals Inc (RCKT)

  7. Rocket Pharmaceuticals Inc (RCKT) Noticias

RCKT

Rocket Pharmaceuticals (RCKT)

Rocket Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:RCKT
FechaHoraFuenteTítuloSímboloCompañía
02/04/202405:00Business WireRocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi AnemiaNASDAQ:RCKTRocket Pharmaceuticals Inc
26/03/202415:01Business WireRocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership TeamNASDAQ:RCKTRocket Pharmaceuticals Inc
04/03/202417:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
29/02/202414:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
26/02/202415:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RCKTRocket Pharmaceuticals Inc
26/02/202415:01Business WireRocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent ProgressNASDAQ:RCKTRocket Pharmaceuticals Inc
16/02/202416:28Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:RCKTRocket Pharmaceuticals Inc
13/02/202406:00Business WireRocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)NASDAQ:RCKTRocket Pharmaceuticals Inc
29/01/202414:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RCKTRocket Pharmaceuticals Inc
02/01/202415:01Business WireRocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RCKTRocket Pharmaceuticals Inc
12/12/202319:42Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RCKTRocket Pharmaceuticals Inc
12/12/202306:00Business WireRocket Pharmaceuticals Appoints R. Keith Woods to Board of DirectorsNASDAQ:RCKTRocket Pharmaceuticals Inc
07/11/202315:40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RCKTRocket Pharmaceuticals Inc
06/11/202315:04Business WireRocket Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent ProgressNASDAQ:RCKTRocket Pharmaceuticals Inc
20/10/202317:37Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:RCKTRocket Pharmaceuticals Inc
19/10/202306:00Business WireRocket Pharmaceuticals Announces Presentations Highlighting Lentiviral and AAV Gene Therapies at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)NASDAQ:RCKTRocket Pharmaceuticals Inc
02/10/202306:00Business WireRocket Pharmaceuticals Announces FDA Acceptance of Biologics License Application with Priority Review for RP-L201 (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)NASDAQ:RCKTRocket Pharmaceuticals Inc
26/09/202315:01Business WireRocket Pharmaceuticals to Participate in the Chardan 7th Annual Genetic Medicines ConferenceNASDAQ:RCKTRocket Pharmaceuticals Inc
20/09/202315:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RCKTRocket Pharmaceuticals Inc
19/09/202315:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RCKTRocket Pharmaceuticals Inc
13/09/202306:37IH Market NewsWednesday’s Wall Street Highlights: Apple, Xpeng, GoDaddy, BP, UBS, Nike, and moreNASDAQ:RCKTRocket Pharmaceuticals Inc
12/09/202323:01Business WireRocket Pharmaceuticals Announces Pricing of Public Offering of Common StockNASDAQ:RCKTRocket Pharmaceuticals Inc
12/09/202316:28Dow Jones NewsRocket Pharmaceuticals Stock Surges 34% on FDA Alignment for Danon Disease TreatmentNASDAQ:RCKTRocket Pharmaceuticals Inc
12/09/202315:55Dow Jones NewsRocket Pharmaceuticals Reaches FDA Alignment in Danon Heart Disease Treatment TrialNASDAQ:RCKTRocket Pharmaceuticals Inc
12/09/202315:02Business WireRocket Pharmaceuticals Announces Proposed Public Offering of Common StockNASDAQ:RCKTRocket Pharmaceuticals Inc
12/09/202315:01Business WireRocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon DiseaseNASDAQ:RCKTRocket Pharmaceuticals Inc
06/09/202315:05Business WireRocket Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:RCKTRocket Pharmaceuticals Inc
10/08/202306:00Business WireRocket Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent ProgressNASDAQ:RCKTRocket Pharmaceuticals Inc
26/06/202318:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RCKTRocket Pharmaceuticals Inc
23/06/202315:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RCKTRocket Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RCKT

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
COIN
SOLUSD
Solana
NYSE
VZ
Verizon Communications
PM
XAUUSD
Gold vs US Dollar
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
NYSE
BAC
Bank of America
NYSE
MCD
McDonalds
NASDAQ
AMZN
Amazon.com
AMEX
XLE
Energy Select Sector SPDR
CCOM
OILBRENT
Brent Oil
AMEX
SPY
SPDR S&P 500
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados